Hm Payson & CO Edwards Lifesciences Corp Transaction History

Hm Payson & CO

$5.49 Billion
Q2 2024

A detailed history of Hm Payson & CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Hm Payson & CO holds 6,105 shares of EW stock, worth $399,755. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,105

Previous 6,083 0.36%

Holding current value

$399,755

Previous $581,000 3.1%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $1,854 - $2,074	22 Added 0.36%	6,105 $563,000
Q4 2023 Feb 13, 2024	BUY	$61.71 - $77.76 $7,713 - $9,720	125 Added 2.1%	6,083 $463,000
Q3 2023 Nov 06, 2023	BUY	$69.28 - $93.38 $141,331 - $190,495	2,040 Added 52.07%	5,958 $412,000
Q2 2023 Jul 17, 2023	SELL	$81.41 - $94.33 $19,538 - $22,639	-240 Reduced 5.77%	3,918 $369,000
Q1 2023 Apr 18, 2023	SELL	$74.26 - $84.51 $94,755 - $107,834	-1,276 Reduced 23.48%	4,158 $343,000
Q4 2022 Feb 06, 2023	BUY	$68.3 - $87.44 $38,726 - $49,578	567 Added 11.65%	5,434 $405,000
Q3 2022 Oct 25, 2022	SELL	$82.37 - $107.29 $37,066 - $48,280	-450 Reduced 8.46%	4,867 $402,000
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $1,211 - $1,795	-14 Reduced 0.26%	5,317 $505,000
Q1 2022 May 12, 2022	BUY	$101.96 - $128.34 $14,682 - $18,480	144 Added 2.78%	5,331 $628,000
Q4 2021 Feb 15, 2022	SELL	$106.37 - $130.68 $37,016 - $45,476	-348 Reduced 6.29%	5,187 $672,000
Q3 2021 Nov 30, 2021	BUY	$102.91 - $122.75 $123,286 - $147,054	1,198 Added 27.62%	5,535 $627,000
Q1 2021 Jun 15, 2021	SELL	$78.68 - $90.67 $11,565 - $13,328	-147 Reduced 3.28%	4,337 $363,000
Q3 2020 Dec 21, 2020	BUY	$67.19 - $87.44 $45,689 - $59,459	680 Added 17.88%	4,484 $358,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $145,921 - $195,145	2,536 Added 200.0%	3,804 $263,000
Q2 2019 Aug 15, 2019	BUY	$55.74 - $64.41 $70,678 - $81,671	1,268 New	1,268 $234,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account